Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Job Safety Analysis for Wet Granulator

Posted on By

Job Safety Analysis for Wet Granulator

JSA for Safe Operation of Wet Granulator

JSA Number JSA/OralDosage/034/2025 Department Oral Dosage
Revision Number V 1.0 Issue Date 01/02/2025
Effective Date 05/02/2025 Review Date 05/02/2026

1. Purpose

The purpose of this JSA is to identify and mitigate potential hazards associated with the operation of the Wet Granulator. This equipment is used in pharmaceutical manufacturing to convert fine powders into larger, uniform granules using liquid binders, which enhances the tablet compression process. Proper handling and operation are essential to prevent mechanical hazards, exposure to liquid binders, and cross-contamination.

2. Scope

This JSA applies to all operators, supervisors, and maintenance personnel involved in using, cleaning, and maintaining the Wet Granulator in the Oral Dosage department. Ensuring compliance with safety measures minimizes risks associated with mechanical moving parts, liquid binder handling, and electrical hazards.

3. Responsibilities

Operators:

  • Follow the standard operating procedure (SOP) while operating the Wet Granulator.
  • Ensure the machine is properly calibrated before use.
  • Wear appropriate Personal Protective Equipment (PPE) to prevent exposure to liquid binders and airborne particles.
  • Monitor granulation parameters, including liquid addition and impeller speed.
  • Ensure proper drainage and cleaning after every batch.
  • Perform post-operation cleaning to prevent cross-contamination.
See also  Job Safety Analysis for Dust Extractor

Supervisors:

  • Ensure compliance with GMP and workplace safety regulations.
  • Monitor machine efficiency and ensure calibration is performed as scheduled.
  • Conduct routine inspections of the Wet
Granulator and maintenance logs.

Safety Officers:

  • Perform risk assessments and ensure compliance with occupational safety standards.
  • Ensure that ventilation and dust control systems are functioning correctly to minimize airborne particles.
  • Verify that PPE, such as gloves and protective aprons, are used correctly.

4. Definitions & Abbreviations

  • PPE: Personal Protective Equipment (e.g., gloves, safety glasses, protective aprons).
  • GMP: Good Manufacturing Practices – Guidelines ensuring product quality and worker safety.
  • LOTO: Lockout/Tagout – A procedure to isolate hazardous energy sources.

5. Procedure

Step Task Description Potential Hazard Risk Level (L/M/H) Control Measures
1 Machine setup and calibration Electrical hazards, incorrect calibration Medium Ensure proper grounding and calibration before operation.
2 Loading powder and liquid binder Manual handling strain, exposure to airborne dust Medium Use lifting aids; wear a respirator and gloves.
3 Starting the granulation process Moving parts entrapment, excessive binder addition High Ensure hands are clear of moving parts; follow SOP for binder dosing.
4 Monitoring granulation Clumping, batch inconsistency High Adjust liquid addition and impeller speed to maintain uniformity.
5 Unloading and transferring granules Cross-contamination, ergonomic strain Medium Follow cleaning procedures and use proper lifting techniques.
6 Cleaning and maintenance Electrical shock, liquid residue High Follow LOTO procedures before servicing; wear PPE during cleaning.

6. Risk Assessment

Likelihood Consequence Risk Level
Rare Minor liquid spillage Low
Possible Respiratory irritation due to airborne powders Medium
Likely Entrapment due to moving parts High

7. Emergency Procedures

  1. In case of excessive powder exposure, move to fresh air and seek medical help.
  2. If the machine malfunctions, shut it down and report to maintenance.
  3. For equipment entrapment, activate the emergency stop and seek immediate assistance.
  4. All incidents must be reported and logged for investigation.

8. Required PPE & Safety Controls

  • Respiratory mask: Prevents inhalation of airborne powder.
  • Safety glasses: Shields eyes from fine dust exposure.
  • Protective clothing: Prevents dust adherence to skin and garments.
  • Machine guards: Ensures safety from moving parts.
  • HEPA filters: Ensures high-efficiency dust extraction.

9. References

  • OSHA 1910.94 – Ventilation Standards.
  • ISO 45001 – Occupational Health & Safety Management.
  • GMP guidelines for wet granulation in pharmaceutical production.

10. Approval Section

Name Designation Signature Date
[Name] Prepared By
[Name] Checked By
[Name] Approved By
See also  Job Safety Analysis for Capsule Printing Machine
Oral Dosage Forms (Tablets & Capsules) Tags:Pharmaceutical Hazard Analysis, Pharmaceutical Job Safety Analysis, Pharmaceutical Risk Assessment, Pharmaceutical Safety Analysis, Pharmaceutical Safety Assessment, Pharmaceutical Safety Audit Checklist, Pharmaceutical Safety Audits, Pharmaceutical Safety Checklist Template, Pharmaceutical Safety Checklists, Pharmaceutical Safety Compliance, Pharmaceutical Safety Documentation, Pharmaceutical Safety Evaluation, Pharmaceutical Safety Guidelines, Pharmaceutical Safety Inspection Checklist, Pharmaceutical Safety Inspections, Pharmaceutical Safety Management, Pharmaceutical Safety Measures, Pharmaceutical Safety Monitoring, Pharmaceutical Safety Plans, Pharmaceutical Safety Policies, Pharmaceutical Safety Procedures, Pharmaceutical Safety Procedures Manual, Pharmaceutical Safety Programs, Pharmaceutical Safety Protocols, Pharmaceutical Safety Regulations, Pharmaceutical Safety Review, Pharmaceutical Safety Risk Assessment, Pharmaceutical Safety SOPs, Pharmaceutical Safety Standards, Pharmaceutical Safety Training

Post navigation

Previous Post: Aerosol: SOP for Handling Deviations in Manufacturing – V 2.0
Next Post: Capsule: SOP for Handling Hazardous Materials in Dispensing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version